Irinotecan hydrochloirde (EBC-12141)
Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
86639-52-3
Purity
95%
SN-38 is the active metabolite of Irinotecan, a chemotherapeutic pro-drug approved for the treatment of advanced colorectal cancer. SN 38 has been used in trials studying the treatment of Cancer, Advanced Solid Tumors, Small Cell Lung Cancer, Metastatic Colorectal Cancer, and Triple Negative Breast Cancer, among others.
Properties
Name
SN-38
Smiles
CCC=1C=2CN3C(=CC4=C(COC(=O)[C@]4(O)CC)C3=O)C2N=C5C=CC(O)=CC15
Targets
Please log in to see this information
The impurity for drugs
SDS
10-hydroxycamptothecin | 20(S)-7-ethyl-10-hydroxycamptothecin | 7-ethyl-10-hydroxy-CPT | 7-ethyl-10-hydroxycamptothecin | Irinotecan Related Compound B | SN-38 | SN‐38 | irinotecan
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$19
2 mg
$19
5 mg
$19
10 mg
$19
15 mg
$19
20 mg
$19
25 mg
$19
30 mg
$19
35 mg
$19
40 mg
$479
45 mg
$19
50 mg
$19
75 mg
$25
100 mg
$POA
Quantity
1
Total amount
$ 19
10-hydroxycamptothecin | 20(S)-7-ethyl-10-hydroxycamptothecin | 7-ethyl-10-hydroxy-CPT | 7-ethyl-10-hydroxycamptothecin | Irinotecan Related Compound B | SN-38 | SN‐38 | irinotecan
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.